Nuclear expression of SOX 18 in cancer cells indicates a poor prognosis in patients with hepatocellular carcinoma

Ya-Zhou Wang,Hua-Hu Guo,Wei-Hua Zhu,Da-Fang Zhang,Xiao Cui,Xin Yu,Xi-Sheng Leng,Shu Li
2016-01-01
Abstract:Transcription factor SOX18 is involved in the development of many tumors, but SOX18 protein expression in hepatocellular carcinoma (HCC) has not been studied. Thus, we measured SOX18 protein expression in HCC and correlated its significance for patients with HCC. After measuring expression and identifying the location of SOX18 in 153 paired HCC and adjacent non-tumor tissues, we found that SOX18 protein was chiefly expressed in the HCC cell nucleus, but was mainly expressed in normal liver cell cytoplasms. Also, nuclear expression of SOX18 protein was associated with TNM stage (P<0.01) and vascular invasion (P<0.01) of HCC. Furthermore, greater nuclear expression of SOX18 protein indicated shorter 3-year overall and disease-free survival of patients with HCC. Thus, SOX18 may be a prognostic marker for HCC.
What problem does this paper attempt to address?